THU-198-Efficacy and safety of glecaprevir/pibrentasvir treatment for 8 weeks in treatment-naive patients with chronic hepatitis C virus infection without cirrhosis or with compensated cirrhosis: Analysis of data pooled from phase 2 and 3 studies.

Authors :: Zuckerman, Eli
Gutierrez, Julio
Ustianowski, Andrew
Naggie, Susanna
Caruntu, Florin Alexandru
Ravendhran, Natarajan
Sigal, Samuel
Barrett, Lisa
Cohen, Stanley
Crown, Eric
Dylla, Doug
Fredrick, Linda
Wang, Stanley
Porcalla, Ariel
Mensa, Federico
Bruno, Savino
Source :: Journal of Hepatology. Apr2019 Supplement, Vol. 70, pe251-e251. 1p.
Publication Year :: 2019

Subjects :: *CHRONIC hepatitis C
*HEPATITIS C virus
*VIRUS diseases
*THERAPEUTICS
*CIRRHOSIS of the liver

Full Text Access

Tools